NEW YORK (GenomeWeb News) – Scripps Health today said that it has received a $3.75 million grant from the Qualcomm Foundation for digital medicine efforts, including genomic-based technologies, conducted at the Scripps Translational Science Institute.

The funds will be used to support a wide variety of efforts including the advancement of clinical trials for wireless biosensor systems, the development of pharmacogenomics tests that would be administered in retail stores, and apps and sensors for tracking and predicting heart attacks, type 1 diabetes, and cancer, said Scripps.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.